Abstract:OBJECTIVE:To investigate the effect of titanium dioxide nanoparticles (TiO2 NPs) on the expression profile of circular ribonucleic acid (circRNA) in human hepatocytes through in vitro cell experiments, and to attempt to understand the potential mechanism of hepatotoxicity through bioinformatics analysis.METHODS:TiO2 NPs were characterized from the aspects of particle size, shape and agglomeration state. The cell counting kit-8 (CCK8) was used to detect the cytotoxicity of TiO2 NPs against human hepatocellular carcinoma cells (HepG2) after exposure to 0, 1.56, 3.13, 6.25, 12.5, 25, 50, 100, and 200 mg/L TiO2 NPs for 24 h or 48 h. The cells were treated at doses of 0 mg/L TiO2 NPs (control group) and 100 mg/L TiO2 NPs (treatment group), and collected after exposure for 48 h, and then RNA from the extracted cell samples was collected and sequenced. The differential circRNAs between the control and the TiO2 NPs treatment groups were screened, and then the enrichment pathway of the differential circRNA target gene was analyzed by multivariate statistics. According to the sequencing results, significantly altered genes and important genes in the significant enrichment pathways were screened, and real-time reverse transcription-polymerase chain reaction (real-time RT-PCR) was performed to verify the results.RESULTS:TiO2 NPs were spherical anatase with a hydrated particle size of (323.50±85.44) nm and a Zeta potential of (-21.00±0.72) mV in a serum-free medium. The results of the CCK8 cytotoxicity assay showed that with the increase of TiO2 NPs concentration, cell viability gradually decreased. A total of 11 478 circRNAs were found by RNA sequencing. Compared with the control groups, TiO2 NPs treatment groups (100 mg/L) had a total of 89 differential circRNAs, of which 59 were up-regulated and 30 were down-regulated. Analysis of the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway showed that the targeted genes of differential circRNAs were mainly enriched in fatty acid degradation, Fanconi anemia pathway, and fatty acid metabolism. The expression levels of circRNA.6730, circRNA.3650 and circRNA.4321 were significantly different between the TiO2 NPs treatment group and the control group, which were consistent with the sequencing results.CONCLUSION:TiO2 NPs can induce changes in circRNA expression profile, and epigenetics may play an important role in the mechanism of hepatotoxicity.

Titanium Dioxide Nanoparticle Absorbed by Hepatoma Cells in Vitro

Selective Anti-Hepatoma Treated with Titanium Oxide Nanoparticles in Vitro

In vitro cytotoxicity of biosynthesized titanium dioxide nanoparticles in human prostate cancer cell lines

The study of proceeding of Tio2 nanoparticle entering human hepatoma cells in vitro

Change of hepatoma cells in infrastructure after inorganic crystal nanoparticles uptaken

New strategy of photodynamic treatment of TiO2 nanofibers combined with celastrol for HepG2 proliferation in vitro.

Effect of Transferrin on Cellular Uptake or Expulsion of Titanium Dioxide Nanoparticles

Mechanism of inhibition of inorganic nanometer size particles on cancer cells

Nano-cerium-element-doped titanium dioxide induces apoptosis of Bel 7402 human hepatoma cells in the presence of visible light

Uptake and Cytotoxicity of Ce(IV) Doped TiO2Nanoparticles in Human Hepatocyte Cell Line L02

Nanotoxicity of TiO2 nanoparticles to erythrocyte in vitro

TiO_2 nanoparticles on cellular ultrastructure and toxic effect of HaCaT cells

In Vitro Biocompatibility Study Of Nano Tio2 Materials

Genotoxicity of TiO2 Nanoparticles in Four Different Human Cell Lines (A549, HEPG2, A172 and SH-SY5Y)

Ultrastructure changes and mechanism of cancer cells induced by inorganic crystal nanoparticles

Effects of the interaction between hydroxyapatite nanoparticles and hepatoma cells

Ce(IV) Doped TiO2 Nanoparticles and the Effect on Proliferation of BEL7402 Human Hepatoma Cells

Cytotoxicity of Titanium Dioxide Nanoparticles Differs in Four Liver Cells from Human and Rat

In Vivo Biocompatibility Studies of Nano Tio2 Materials

[Effects of Titanium Dioxide Nanoparticles on Circrna Expression Profiles in Human Hepatocellular Carcinoma Cells HepG2].

Endocytosis of Titanium Dioxide Nanoparticles in Prostate Cancer PC-3M Cells